Tidomet CR

Tidomet Cr contains Levodopa (200mg) + Carbidopa (50mg) and is used for Parkinson's disease. Prescription required.

Treatment of Parkinson's disease

Tidomet CR Tablet is a combination of two medicines: Levodopa and Carbidopa which treats Parkinsonism. Levodopa is a dopamine precursor which gets converted to dopamine, a chemical messenger that controls movement in the brain. Carbidopa is a peripheral decarboxylase inhibitor which prevents breakdown of levodopa, allowing it to enter the brain and increase dopamine levels.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tidomet CR Tablet is to be taken on an empty stomach. Avoid Tidomet CR Tablet with high protein meals such as cottage cheese, Swiss cheese, protein powder, eggs and milk.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Never stop a Parkinson's medicine suddenly — this can cause a severe and dangerous deterioration. Dose timing matters a great deal in Parkinson's disease. Take it at exactly the times prescribed. Report sudden daytime sleep attacks, hallucinations, or new gambling, spending or other impulsive behaviour — these are recognised effects and the dose may need review. Rise slowly from sitting or lying; a drop in blood pressure on standing is common.

Anti-emetics such as metoclopramide and some antipsychotics can worsen Parkinson's symptoms. High-protein meals can reduce the absorption of levodopa — ask your doctor about timing.

Store below 30°C in the original pack, away from direct sunlight and moisture. Keep out of the reach of children.